← Back to Search

Device

Transcranial Magnetic Stimulation for Tourette Syndrome (STOP-TIC Trial)

N/A
Recruiting
Led By Jessica Frey, MD
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 months

Summary

This trial will study if using a magnetic stimulation followed by therapy can reduce tics in adults with Tourette's Syndrome. It will compare changes in tic frequency/severity + neurophysiological changes.

Who is the study for?
Adults over 18 with Tourette Syndrome and moderate tic severity can join this study. It's not for those with metal in their brain, pregnant individuals, people with seizures or epilepsy history, anyone who can't have an fMRI, or if another condition prevents them from doing CBIT therapy.
What is being tested?
The trial is testing whether a technique called rTMS enhances the effects of a tic treatment known as CBIT in adults with Tourette's. Participants are randomly assigned to get either real rTMS or a pretend version before starting eight sessions of CBIT.
What are the potential side effects?
rTMS may cause discomfort at the stimulation site, headache, lightheadedness, or twitching facial muscles during treatment. Rarely it could induce seizures but is generally considered safe.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Modified Rush Videotape Tic Rating Scale (mRVTRS)
Yale Global Tic Severity Scale (YGTSS)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active rTMSActive Control1 Intervention
Patients receiving active rTMS
Group II: Sham rTMSPlacebo Group1 Intervention
Patients receiving sham rTMS

Find a Location

Who is running the clinical trial?

University of FloridaOTHER
1,402 Previous Clinical Trials
767,003 Total Patients Enrolled
7 Trials studying Tourette Syndrome
122 Patients Enrolled for Tourette Syndrome
Tourette Association of AmericaOTHER
11 Previous Clinical Trials
480 Total Patients Enrolled
11 Trials studying Tourette Syndrome
480 Patients Enrolled for Tourette Syndrome
West Virginia UniversityLead Sponsor
185 Previous Clinical Trials
64,753 Total Patients Enrolled

Media Library

Transcranial Magnetic Stimulation (Device) Clinical Trial Eligibility Overview. Trial Name: NCT05705999 — N/A
Tourette Syndrome Research Study Groups: Sham rTMS, Active rTMS
Tourette Syndrome Clinical Trial 2023: Transcranial Magnetic Stimulation Highlights & Side Effects. Trial Name: NCT05705999 — N/A
Transcranial Magnetic Stimulation (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05705999 — N/A
~7 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top